Pathomorphology is correlated with visual acuity changes

Article

The visual acuity (VA) in diabetic retinopathy is associated with the retinal oedema in the parafovea and the pathomorphology and photoreceptor status at the fovea

The visual acuity (VA) in diabetic retinopathy is associated with the retinal oedema in the parafovea and the pathomorphology and photoreceptor status at the fovea claims a study in the American Journal of Ophthalmology.

Dr Tomoaki Murakami and his team at the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan, used 125 consecutive eyes of 73 patients in a retrospective, observational study.

All patients underwent spectralis optical coherence tomography (OCT) and the outcome measures were status of external limiting membrane (ELM), cystic changes and pathomorphology. The correlation of logarithm of the minimal angle of resolution (logMAR) was studied.

Three types of pathomorphology were identified at the fovea. These included cystoid macular oedema (CME), serous retinal detachment (SRD) and a lack of CME or SRD. The average logMAR with the CME pathomorphology was worse than the SRD pathomorphology.

It was found that parafoveal thickening or disturbed ELM was strongly correlated with low VA. However, SRD did not have a strong correlation with VA.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.